Search

29 results for “Editorial”

• EditorialOpen Access

  Why patients in pain cannot get “God’s own medicine?”

  Gitanjali Batmanabane

  Vol. 5 · Issue 2 · pp. 81–2

  https://doi.org/10.4103/0976-500X.130040
  Full text ↗PDF

• EditorialOpen Access

  Boosting the brand image

  Vijay Thawani, Priyanka Singh, Heenopama Thakur

  Vol. 6 · Issue 1 · pp. 1–2

  https://doi.org/10.4103/0976-500X.149126
  Full text ↗PDF

• EditorialOpen Access

  Push, promote or educate…musings of a pharmacologist on drug promotion

  Chanolean Shashindran

  Vol. 5 · Issue 4 · pp. 225–226

  https://doi.org/10.4103/0976-500X.142427
  Full text ↗PDF

• EditorialOpen Access

  Bridging the gap between alternative medicine and evidence-based medicine

  Mostafa Yakoot

  Vol. 4 · Issue 2 · pp. 83–85

  https://doi.org/10.4103/0976-500X.110868
  Full text ↗PDF

• EditorialOpen Access

  Eminence or Evidence? The Volatility, Uncertainty, Complexity, and Ambiguity in Healthcare

  M. K. Unnikrishnan

  Vol. 8 · Issue 1 · pp. 1–2

  https://doi.org/10.4103/jpp.JPP_12_17
  Full text ↗PDF

• EditorialOpen Access

  Ethics of expert opinion and the observations of the department-related parliamentary standing committee on the CDSCO

  Amar Jesani

  Vol. 3 · Issue 4 · pp. 297–299

  https://doi.org/10.4103/0976-500X.103684
  Full text ↗PDF

• EditorialOpen Access

  Clinical trial ethics in India: One step forward, two steps back

  Anant Bhan

  Vol. 3 · Issue 2 · pp. 95–97

  https://doi.org/10.4103/0976-500X.95501
  Full text ↗PDF

• EditorialOpen Access

  [Downloaded free from http://www.jpharmacol.com on Wednesday, October 13, 2021, IP: 157.45.222.78]

  Raveendran: Animal experimentation in postgraduate training Journal of Pharmacology and Pharmacotherapeutics | July-September | Vol | Issue

  Vol. 5 · Issue 3 · pp. 179–180

  https://doi.org/10.4103/0976-500X.136095
  Full text ↗PDF

• EditorialOpen Access

  Improving quality of medical education in India: The need to value and recognize academic scholarship

  Thomas V. Chacko

  Vol. 4 · Issue 3 · pp. 171–173

  https://doi.org/10.4103/0976-500X.114595
  Full text ↗PDF

• EditorialOpen Access

  Trivializing assessment: A key factor in undermining the standards of medical education

  Manikandan S

  Vol. 6 · Issue 4 · pp. 195–197

  https://doi.org/10.4103/0976-500X.171875
  Full text ↗PDF

• EditorialOpen Access

  Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance

  Emilio Russo, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. 1–3

  https://doi.org/10.4103/0976-500X.120938
  Full text ↗PDF

• EditorialOpen Access

  The three Rs of written assessment: The JIPMER experience

  Manikandan S, Gitanjali B

  Vol. 7 · Issue 3 · pp. 115–116

  https://doi.org/10.4103/0976-500X.189650
  Full text ↗PDF

• EditorialOpen Access

  Pioglitazone suspension and its aftermath: A wake up call for the Indian drug regulatory authorities

  Arif Hashmi

  Vol. 4 · Issue 4 · pp. 227–229

  https://doi.org/10.4103/0976-500X.119705
  Full text ↗PDF

• EditorialOpen Access

  The National Formulary of India 2010: Thorough and extensive revision of the preprint version needed

  B. Gitanjali

  Vol. 2 · Issue 4 · pp. 219–20

  https://doi.org/10.4103/0976-500X.85928
  Full text ↗PDF

• EditorialOpen Access

  Calling a spade a spade... why editors are uncomfortable to say it as it is

  Gitanjali B.

  Vol. 3 · Issue 1 · pp. 1–3

  https://doi.org/10.4103/0976-500X.92490
  Full text ↗PDF

• EditorialOpen Access

  Antidotes: Where are they when needed?

  Gitanjali Batmanabane

  Vol. 5 · Issue 1 · pp. 1–3

  https://doi.org/10.4103/0976-500X.124403
  Full text ↗PDF

• EditorialOpen Access

  Are we going to allow the last nail on the coffin of animal experimentation to be nailed?

  Gitanjali B.

  Vol. 3 · Issue 3 · pp. 215–216

  https://doi.org/10.4103/0976-500X.99415
  Full text ↗PDF

• EditorialOpen Access

  Are we moving towards a new definition of essential medicines?

  Manikandan S

  Vol. 6 · Issue 3 · pp. 123–5

  https://doi.org/10.4103/0976-500X.162008
  Full text ↗PDF

• EditorialOpen Access

  Expedited drug review process: Fast, but flawed

  Krishnan Vengadaraga Chary

  Vol. 7 · Issue 2 · pp. 57–58

  https://doi.org/10.4103/0976-500X.184768
  Full text ↗PDF

• EditorialOpen Access

  A tale of too many strengths: Can we minimize prescribing errors and dispensing errors with so many formulations in the market?

  Gitanjali B.

  Vol. 2 · Issue 3 · pp. 147–149

  https://doi.org/10.4103/0976-500X.83277
  Full text ↗PDF